12:00 AM
 | 
Jan 30, 2012
 |  BC Week In Review  |  Company News  |  Deals

Arctic Partners, Opko deal

Opko acquired exclusive rights to two kallikrein family biomarkers from Arctic Partners. Opko said it will develop a prostate cancer...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >